Log In
BCIQ
Print this Print this
 

GNbAC1

  Manage Alerts
Collapse Summary General Information
Company GeNeuro S.A.
DescriptionHumanized mAb targeting the envelope protein of human endogenous retrovirus group W member 1 (HERVW; ERVW-1)
Molecular Target Endogenous retrovirus group W member 1 (HERVW) (ERVW-1)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$455.0M

0

$408.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/02/2014

$455.0M

0

$408.0M

Get a free BioCentury trial today